Search research articles
Contact Us
Filters
Showing results (181-190 of 635) with videos related to
Page
of 64
Sort By:
Journal of Affective Disorders
|
August 28, 2022
General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity
Julio C Nunes, Megan K Carroll, Kenneth W Mahaffey, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 10, 2011
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
Michael P Hudson, Paul W Armstrong, William W O'Neil, et al.
European Heart Journal
|
December 3, 2009
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction
Michael C Tjandrawidjaja, Yuling Fu, Cynthia M Westerhout, et al.
Circulation
|
March 30, 2026
Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials
Sreekanth Vemulapalli, Karla Pena Guerra, Daniel Wojdyla, et al.
The Lancet. Rheumatology
|
January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program
JingWei Li, Sunil V Badve, Zien Zhou, et al.
Journal of the American Heart Association
|
January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Clare Arnott, Qiang Li, Amy Kang, et al.
American Heart Journal
|
March 30, 2013
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Benjamin A Steinberg, DaJuanicia N Holmes, Michael D Ezekowitz, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 13, 2017
Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Ryan Orgel, Daniel Wojdyla, David Huberman, et al.
Circulation. Cardiovascular Imaging
|
May 14, 2026
Impact of the 2025 ASE Guidelines on the Classification of LV Diastolic Dysfunction in the Community: A Project Baseline Health Study
Nancy Herrera-Leaño, Bettia Celestin, Everton Santana, et al.
American Heart Journal
|
July 12, 2011
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction"
John K French, Paul W Armstrong, Eric Cohen, et al.
Page
of 64
Search research articles
Search
Showing results (181-190 of 635) with videos related to
Sort By:
Page
of 64
Journal of Affective Disorders
|
August 28, 2022
General Anxiety Disorder-7 Questionnaire as a marker of low socioeconomic status and inequity
Julio C Nunes, Megan K Carroll, Kenneth W Mahaffey, et al.
Circulation. Cardiovascular Quality and Outcomes
|
February 10, 2011
Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
Michael P Hudson, Paul W Armstrong, William W O'Neil, et al.
European Heart Journal
|
December 3, 2009
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction
Michael C Tjandrawidjaja, Yuling Fu, Cynthia M Westerhout, et al.
Circulation
|
March 30, 2026
Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials
Sreekanth Vemulapalli, Karla Pena Guerra, Daniel Wojdyla, et al.
The Lancet. Rheumatology
|
January 17, 2024
The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program
JingWei Li, Sunil V Badve, Zien Zhou, et al.
Journal of the American Heart Association
|
January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Clare Arnott, Qiang Li, Amy Kang, et al.
American Heart Journal
|
March 30, 2013
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
Benjamin A Steinberg, DaJuanicia N Holmes, Michael D Ezekowitz, et al.
Circulation. Cardiovascular Quality and Outcomes
|
May 13, 2017
Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Ryan Orgel, Daniel Wojdyla, David Huberman, et al.
Circulation. Cardiovascular Imaging
|
May 14, 2026
Impact of the 2025 ASE Guidelines on the Classification of LV Diastolic Dysfunction in the Community: A Project Baseline Health Study
Nancy Herrera-Leaño, Bettia Celestin, Everton Santana, et al.
American Heart Journal
|
July 12, 2011
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction"
John K French, Paul W Armstrong, Eric Cohen, et al.
Page
of 64